- Home
- ABEO vs ACRE Comparison
ABEO vs ACRE Comparison
Compare ABEO & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | ACRE |
|---|---|---|
| Founded | 1974 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 254.1M |
| IPO Year | 2005 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ABEO | ACRE |
|---|---|---|
| Price | $5.45 | $5.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $20.00 | $5.38 |
| AVG Volume (30 Days) | ★ 1.0M | 416.2K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.58% |
| EPS Growth | ★ 165.16 | 26.17 |
| EPS | N/A | ★ 1.35 |
| Revenue | $2,998,000.00 | ★ $54,833,000.00 |
| Revenue This Year | $1,024.31 | N/A |
| Revenue Next Year | $145.42 | $16.28 |
| P/E Ratio | ★ N/A | $3.74 |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $4.05 |
| 52 Week High | $7.54 | $5.89 |
Technical Indicators
Market Signals| Indicator | ABEO | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 46.84 | 51.78 |
| Support Level | $5.20 | $4.58 |
| Resistance Level | $5.54 | $5.15 |
| Average True Range (ATR) | 0.24 | 0.12 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 39.88 | 82.52 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.